NDL 0.00% 3.8¢ neurodiscovery limited

Hello??!! This drug just failed a Phase I trial, so what makes...

  1. 498 Posts.
    Hello??!! This drug just failed a Phase I trial, so what makes you think it will do any better for something it is LESS suited for. Drug candidates dug up from the graveyard are cheap to trial, but rarely have a pulse.

    NDL is way too expensive right now. My valuation model suggests fair value at 10 - 12 cents.
 
watchlist Created with Sketch. Add NDL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.